Cyclerion Therapeutics In...

NASDAQ: CYCN · Real-Time Price · USD
3.08
-0.09 (-2.84%)
At close: Jun 06, 2025, 10:01 AM

Cyclerion Therapeutics Statistics

Share Statistics

Cyclerion Therapeutics has 3.21M shares outstanding. The number of shares has increased by 0% in one year.

3.21M
0%
0%
0.02%
n/a
1,792
8.8%

Short Selling Information

The latest short interest is 25.09K, so 0.82% of the outstanding shares have been sold short.

25.09K
0.82%
1.03%
1.56

Valuation Ratios

The PE ratio is -2.65 and the forward PE ratio is -0.15. Cyclerion Therapeutics's PEG ratio is 0.03.

-2.65
-0.15
4.05
0.1
0.92
-1.87
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cyclerion Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.83, with a Debt / Equity ratio of 0.

5.83
5.83
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$2,000,000
$-3,057,000
1
0.21
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 19.62% in the last 52 weeks. The beta is 1.55, so Cyclerion Therapeutics's price volatility has been higher than the market average.

1.55
19.62%
2.94
2.89
53.64
20,373

Income Statement

In the last 12 months, Cyclerion Therapeutics had revenue of 2M and earned -3.06M in profits. Earnings per share was -1.21.

2M
2M
-3.63M
-3.06M
-3.63M
-3.63M
-1.21
Full Income Statement

Balance Sheet

The company has 3.23M in cash and 0 in debt, giving a net cash position of 3.23M.

3.23M
n/a
n/a
-267.49M
9.85M
3.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.33M and capital expenditures 0, giving a free cash flow of -4.33M.

-4.33M
n/a
-4.33M
-1.72
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -181.4% and -152.85%.

100%
-181.4%
-152.85%
-152.85%
-181.4%
-181.4%
-216.65%

Dividends & Yields

CYCN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CYCN.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 16, 2023. It was a backward split with a ratio of 1:20.

May 16, 2023
backward
1:20

Scores

-33.8
2